story of the week
Plasma KIM-1 Is Associated With Recurrence Risk After Nephrectomy for Localized Renal Cell Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Plasma KIM-1 Is Associated With Recurrence Risk After Nephrectomy for Localized Renal Cell Carcinoma: A Trial of the ECOG-ACRIN Research Group (E2805)
Clin. Cancer Res 2021 Apr 08;[EPub Ahead of Print], W Xu, M Puligandla, B Halbert, NB Haas, KT Flaherty, RG Uzzo, JP Dutcher, RS DiPaola, V Sabbisetti, RS BhattFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.